{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:39:41Z","timestamp":1791355181387,"version":"4.3.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.bbalip.2014.03.001","type":"journal-article","created":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T13:01:22Z","timestamp":1394802082000},"page":"880-887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Deficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycin"],"prefix":"10.1016","volume":"1841","author":[{"given":"David S.","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha J.","family":"Grevengoed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florencia","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monte S.","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalind A.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2014.03.001_bb0005","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1749-6632.2009.05100.x","article-title":"Return to the fetal gene program: a suggested metabolic link to gene expression in the heart","volume":"1188","author":"Taegtmeyer","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0010","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/MOL.0b013e32833884bb","article-title":"Acyl-coenzyme A synthetases in metabolic control","volume":"21","author":"Ellis","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0015","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bbalip.2009.09.024","article-title":"Acyl-CoA synthesis, lipid metabolism and lipotoxicity","volume":"1801","author":"Li","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2014.03.001_bb0020","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1128\/MCB.01085-10","article-title":"Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs fatty acid oxidation and induces cardiac hypertrophy","volume":"31","author":"Ellis","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cmet.2010.05.012","article-title":"Adipose acyl-CoA synthetase-1 directs fatty acids toward beta-oxidation and is required for cold thermogenesis","volume":"12","author":"Ellis","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0030","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/j.1432-1033.2004.04151.x","article-title":"Covalent activation of heart AMP-activated protein kinase in response to physiological concentrations of long-chain fatty acids","volume":"271","author":"Clark","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0035","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0040","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1152\/physrev.1992.72.4.881","article-title":"Fatty acid homeostasis in the normoxic and ischemic heart","volume":"72","author":"van der Vusse","year":"1992","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0045","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0050","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.yjmcc.2011.02.004","article-title":"Three 4-letter words of hypertension-related cardiac hypertrophy: TRPC, mTOR, and HDAC","volume":"50","author":"Kurdi","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0055","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1172\/JCI24682","article-title":"Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure","volume":"115","author":"Shiojima","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0060","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000057979.36322.88","article-title":"Rapamycin attenuates load-induced cardiac hypertrophy in mice","volume":"107","author":"Shioi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2014.03.001_bb0065","doi-asserted-by":"crossref","first-page":"H75","DOI":"10.1152\/ajpheart.00241.2012","article-title":"Cardiac mTOR protects the heart against ischemia\u2013reperfusion injury","volume":"303","author":"Aoyagi","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0070","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1128\/MCB.22.8.2799-2809.2002","article-title":"Akt\/protein kinase B promotes organ growth in transgenic mice","volume":"22","author":"Shioi","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0075","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1210\/en.2007-0099","article-title":"Rapamycin prevents thyroid hormone-induced cardiac hypertrophy","volume":"148","author":"Kuzman","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbalip.2014.03.001_bb0080","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.yjmcc.2011.10.015","article-title":"Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways","volume":"52","author":"Clemente","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0085","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/CIRCULATIONAHA.110.977066","article-title":"Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice","volume":"123","author":"Shende","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2014.03.001_bb0090","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.cell.2006.06.055","article-title":"TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth","volume":"126","author":"Inoki","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbalip.2014.03.001_bb0095","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1172\/JCI31757","article-title":"Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins","volume":"117","author":"Li","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0100","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/cvr\/cvp335","article-title":"Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers","volume":"85","author":"Jearawiriyapaisarn","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0105","doi-asserted-by":"crossref","first-page":"H1563","DOI":"10.1152\/ajpheart.00384.2003","article-title":"Developmental changes in left and right ventricular diastolic filling patterns in mice","volume":"285","author":"Zhou","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0110","first-page":"357","article-title":"New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function\u2014a study in normals and dilated cardiomyopathy","volume":"26","author":"Tei","year":"1995","journal-title":"J. Cardiol."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0115","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0025-6196(12)61059-3","article-title":"Effects of age on left ventricular dimensions and filling dynamics in 117 normal persons","volume":"69","author":"Klein","year":"1994","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0120","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1053\/euhj.2000.2246","article-title":"Tei-index in patients with mild-to-moderate congestive heart failure","volume":"21","author":"Bruch","year":"2000","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0125","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1067\/mje.2002.120977","article-title":"Severe aortic valve stenosis with preserved and reduced systolic left ventricular function: diagnostic usefulness of the Tei index","volume":"15","author":"Bruch","year":"2002","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1258\/la.2007.06001e","article-title":"Echocardiographic assessment of global left ventricular function in mice","volume":"43","author":"Stypmann","year":"2009","journal-title":"Lab. Anim."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0135","doi-asserted-by":"crossref","first-page":"7173","DOI":"10.1016\/S0021-9258(17)34480-0","article-title":"Limited palmitoyl-CoA penetration into microsomal vesicles as evidenced by a highly latent ethanol acyltransferase activity","volume":"253","author":"Polokoff","year":"1978","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0140","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.yjmcc.2009.11.012","article-title":"Multiple and diverse coexpression, location, and regulation of additional SERCA2 and SERCA3 isoforms in nonfailing and failing human heart","volume":"48","author":"Dally","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0145","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.yjmcc.2010.04.017","article-title":"Correcting diastolic dysfunction by Ca2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy","volume":"49","author":"Li","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0150","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/01.HYP.0000257914.80918.72","article-title":"FK506 binding protein 12\/12.6 depletion increases endothelial nitric oxide synthase threonine 495 phosphorylation and blood pressure","volume":"49","author":"Long","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.bbalip.2014.03.001_bb0155","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1161\/01.CIR.0000150332.42276.69","article-title":"Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs","volume":"110","author":"Lindenfeld","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2014.03.001_bb0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/01.CIR.0000151609.60618.3C","article-title":"Drug therapy in the heart transplant recipient: part III: common medical problems","volume":"111","author":"Lindenfeld","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2014.03.001_bb0165","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1023\/A:1006974330613","article-title":"Signal transduction and transcriptional adaptation in embryonic heart development and during myocardial hypertrophy","volume":"196","author":"Ghatpande","year":"1999","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0170","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbalip.2006.11.007","article-title":"Ontogeny of mRNA expression and activity of long-chain acyl-CoA synthetase (ACSL) isoforms in Mus musculus heart","volume":"1771","author":"de Jong","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2014.03.001_bb0175","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1440-1681.2007.04585.x","article-title":"Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure","volume":"34","author":"McMullen","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0180","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1126\/science.1215135","article-title":"Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity","volume":"335","author":"Lamming","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2014.03.001_bb0185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/187152509787047603","article-title":"mTOR in growth and protection of hypertrophying myocardium","volume":"7","author":"Balasubramanian","year":"2009","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0190","doi-asserted-by":"crossref","first-page":"e004796","DOI":"10.1161\/JAHA.113.004796","article-title":"Glucose regulation of load-induced mTOR signaling and ER stress in mammalian heart","volume":"2","author":"Sen","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0195","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1161\/CIRCULATIONAHA.108.832915","article-title":"Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity","volume":"119","author":"Yan","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2014.03.001_bb0200","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.1073\/pnas.1132094100","article-title":"Myocardial recovery from ischemia is impaired in CD36-null mice and restored by myocyte CD36 expression or medium-chain fatty acids","volume":"100","author":"Irie","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0205","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/01.RES.82.7.773","article-title":"Hypertrophy, pathology, and molecular markers of cardiac pathogenesis","volume":"82","author":"Vikstrom","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0210","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/BST0370217","article-title":"A complex interplay between Akt, TSC2 and the two mTOR complexes","volume":"37","author":"Huang","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0215","doi-asserted-by":"crossref","first-page":"E592","DOI":"10.1152\/ajpendo.90645.2008","article-title":"Amino acid regulation of TOR complex 1","volume":"296","author":"Avruch","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0220","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1161\/HYPERTENSIONAHA.109.138818","article-title":"Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive rats","volume":"54","author":"Soesanto","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.bbalip.2014.03.001_bb0225","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cardiores.2007.05.004","article-title":"Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart","volume":"76","author":"Sharma","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0230","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1475-2840-11-63","article-title":"GLUT4, GLUT1, and GLUT8 are the dominant GLUT transcripts expressed in the murine left ventricle","volume":"11","author":"Aerni-Flessner","year":"2012","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0235","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1161\/hc4901.100526","article-title":"Metabolic gene expression in fetal and failing human heart","volume":"104","author":"Razeghi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2014.03.001_bb0240","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbalip.2014.03.001_bb0245","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1210\/en.2004-0921","article-title":"Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance","volume":"146","author":"Khamzina","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbalip.2014.03.001_bb0250","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.2337\/db13-0106","article-title":"Evidence for rapamycin toxicity in pancreatic beta-cells and a review of the underlying molecular mechanisms","volume":"62","author":"Barlow","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2014.03.001_bb0255","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.2337\/db09-1324","article-title":"Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue","volume":"59","author":"Houde","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2014.03.001_bb0260","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/CIRCIMAGING.110.961623","article-title":"Established and novel clinical applications of diastolic function assessment by echocardiography","volume":"4","author":"Oh","year":"2011","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.bbalip.2014.03.001_bb0265","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/j.jvca.2009.06.009","article-title":"Recent progress in heart failure treatment and heart transplantation","volume":"23","author":"Augoustides","year":"2009","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0270","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1399-3046.2005.00365.x","article-title":"Cardiac function in children post-orthotopic liver transplantation: echocardiographic parameters and biochemical markers of subclinical cardiovascular damage","volume":"9","author":"Shalev","year":"2005","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0275","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/TP.0b013e3182603297","article-title":"Late calcineurin inhibitor withdrawal prevents progressive left ventricular diastolic dysfunction in renal transplant recipients","volume":"94","author":"Mourer","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.bbalip.2014.03.001_bb0280","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.yjmcc.2010.10.018","article-title":"Impact of long-term caloric restriction on cardiac senescence: caloric restriction ameliorates cardiac diastolic dysfunction associated with aging","volume":"50","author":"Shinmura","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0285","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/TP.0b013e318189049a","article-title":"Sirolimus as primary immunosuppressant reduces left ventricular mass and improves diastolic function of the cardiac allograft","volume":"86","author":"Raichlin","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.bbalip.2014.03.001_bb0290","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.tcm.2009.12.005","article-title":"Metabolic therapy at the crossroad: how to optimize myocardial substrate utilization?","volume":"19","author":"Kolwicz","year":"2009","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0295","doi-asserted-by":"crossref","first-page":"E1104","DOI":"10.1152\/ajpendo.2000.279.5.E1104","article-title":"Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db\/db) mice","volume":"279","author":"Belke","year":"2000","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0300","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.2337\/diabetes.53.9.2366","article-title":"Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob\/ob mouse hearts","volume":"53","author":"Mazumder","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2014.03.001_bb0305","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/01.CIR.96.2.676","article-title":"Glycogen metabolism in the aerobic hypertrophied rat heart","volume":"96","author":"Allard","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2014.03.001_bb0310","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00000441-199907000-00006","article-title":"Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms","volume":"318","author":"Barger","year":"1999","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0315","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s11906-003-0052-7","article-title":"Transcriptional regulation of energy substrate metabolism in normal and hypertrophied heart","volume":"5","author":"Tian","year":"2003","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.bbalip.2014.03.001_bb0320","doi-asserted-by":"crossref","first-page":"C1256","DOI":"10.1152\/ajpcell.00338.2010","article-title":"mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy","volume":"299","author":"Song","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198114000420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198114000420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T23:31:30Z","timestamp":1648596690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198114000420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1388198114000420"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2014.03.001","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycin","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2014.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}